|
NBPF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.956000E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.203300E-03 |
| Normal-vs-Stage2 |
3.562100E-02 |
| Normal-vs-Stage3 |
6.760000E-04 |
| Normal-vs-Stage4 |
1.283970E-03 |
| Stage1-vs-Stage2 |
9.910000E-01 |
| Stage1-vs-Stage3 |
5.711700E-02 |
| Stage1-vs-Stage4 |
9.331600E-02 |
| Stage2-vs-Stage3 |
1.681650E-01 |
| Stage2-vs-Stage4 |
2.044800E-01 |
| Stage3-vs-Stage4 |
9.516400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.377600E-03 |
| Normal-vs-AfricanAmerican |
8.044800E-01 |
| Normal-vs-Asian |
6.029600E-02 |
| Caucasian-vs-AfricanAmerican |
1.861890E-02 |
| Caucasian-vs-Asian |
3.110400E-01 |
| AfricanAmerican-vs-Asian |
1.965230E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.214600E-04 |
| Normal-vs-Female |
4.380000E-03 |
| Male-vs-Female |
5.635100E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.473520E-02 |
| Normal-vs-Age(41-60Yrs) |
8.571000E-04 |
| Normal-vs-Age(61-80Yrs) |
3.121800E-03 |
| Normal-vs-Age(81-100Yrs) |
9.350200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.243400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.236000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.117200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.362000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.525000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.144000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.977280E-03 |
| Classical-VS-Follicular |
4.547200E-01 |
| Classical-VS-Other |
2.051200E-01 |
| Classical-VS-Normal |
1.921600E-02 |
| Tall-VS-Follicular |
4.697900E-02 |
| Tall-VS-Other |
9.701200E-01 |
| Tall-VS-Normal |
7.95410000000718E-05 |
| Follicular-VS-Other |
4.107000E-01 |
| Follicular-VS-Normal |
1.043600E-02 |
| Other-VS-Normal |
5.840100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.903600E-03 |
| Normal-vs-N1 |
2.580200E-04 |
| N0-vs-N1 |
3.316000E-02 |
|
|
